Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Landais

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Trials|January 10, 2018
Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study)Géraldine Leguelinel-Blache, Christel Castelli, Clarisse Roux-Marson, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 28, 2007
Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patientsVirginie Colomb, Myriam Dabbas-Tyan, Pierre Taupin, et al.
Arthritis and Rheumatism|April 11, 2003
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typePierre Quartier, Pierre Taupin, Franck Bourdeaut, et al.
Annals of the Rheumatic Diseases|December 22, 2010
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Pierre Quartier, Florence Allantaz, Rolando Cimaz, et al.
Clinical Chemistry|August 8, 2019
Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective StudyRenaud Garrel, Martine Mazel, Françoise Perriard, et al.
Lancet (London, England)|February 25, 2003
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99Corinne Antoine, Susanna Müller, Andrew Cant, et al.
Studies in Health Technology and Informatics|September 16, 2010
CEMARA an information system for rare diseasesPaul Landais, Claude Messiaen, Ana Rath, et al.
Studies in Health Technology and Informatics|May 20, 2008
CEMARA: a Web dynamic application within a N-tier architecture for rare diseasesClaude Messiaen, Loïc Le Mignot, Ana Rath, et al.
Blood|October 24, 2002
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000Reinhard A Seger, Tayfun Gungor, Bernd H Belohradsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal CancerRenaud Garrel, Gilles Poissonnet, Antoine Moyà Plana, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Trials|January 10, 2018
Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study)Géraldine Leguelinel-Blache, Christel Castelli, Clarisse Roux-Marson, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 28, 2007
Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patientsVirginie Colomb, Myriam Dabbas-Tyan, Pierre Taupin, et al.
Arthritis and Rheumatism|April 11, 2003
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset typePierre Quartier, Pierre Taupin, Franck Bourdeaut, et al.
Annals of the Rheumatic Diseases|December 22, 2010
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Pierre Quartier, Florence Allantaz, Rolando Cimaz, et al.
Clinical Chemistry|August 8, 2019
Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective StudyRenaud Garrel, Martine Mazel, Françoise Perriard, et al.
Lancet (London, England)|February 25, 2003
Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99Corinne Antoine, Susanna Müller, Andrew Cant, et al.
Studies in Health Technology and Informatics|September 16, 2010
CEMARA an information system for rare diseasesPaul Landais, Claude Messiaen, Ana Rath, et al.
Studies in Health Technology and Informatics|May 20, 2008
CEMARA: a Web dynamic application within a N-tier architecture for rare diseasesClaude Messiaen, Loïc Le Mignot, Ana Rath, et al.
Blood|October 24, 2002
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000Reinhard A Seger, Tayfun Gungor, Bernd H Belohradsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal CancerRenaud Garrel, Gilles Poissonnet, Antoine Moyà Plana, et al.
Pageof 13